Diseases of the Retina Practice Questions

Q: A patient presented with sudden onset of floaters and perception of a curtain (veil) falling in front of the eye. Which one of the following is the most appropriate diagnosis?

Retinal detachment. **Explanation:** **1. Why Retinal Detachment (RD) is the Correct Answer:** The clinical triad of **photopsia** (flashes of light), **floaters** (due to vitreous condensation or RPE release), and a **painless "curtain-like" loss of vision** is the classic presentation of Rhegmatogenous Retinal Detachment. The "curtain falling" sensation occurs as the subretinal fluid accumulates, causing the sensory retina to separate from the retinal pigment epithelium (RPE), leading to a progressive visual field defect corresponding to the area of detachment. **2. Why the Other Options are Incorrect:** * **Eales Disease:** This is an idiopathic peripheral perivasculitis. While it can lead to RD or vitreous hemorrhage, its primary presentation is usually recurrent, painless vitreous hemorrhage in young males. * **Vitreous Hemorrhage:** While this presents with sudden floaters and blurred vision, it is typically described as "black streaks" or a "red haze" rather than a distinct curtain-like field defect. * **Glaucoma:** Acute Congestive Glaucoma presents with sudden vision loss, but it is associated with **severe pain**, halos around lights, and a cloudy cornea, not a "curtain" effect. Chronic glaucoma causes peripheral field loss so gradual that patients are often asymptomatic until late stages. **3. High-Yield Clinical Pearls for NEET-PG:** * **Shafer’s Sign:** The presence of "tobacco dust" (pigment cells) in the anterior vitreous is pathognomonic for a retinal tear. * **Most Common Site:** The **Superior-Temporal** quadrant is the most common site for retinal breaks. * **Surgical Management:** For Rhegmatogenous RD, the gold standard is **Scleral Buckling** or **Pars Plana Vitrectomy (PPV)** with internal tamponade (gas or silicone oil). * **Differential:** If the curtain "comes and goes" (transient), think **Amaurosis Fugax** (carotid artery disease); if it is "persistent," think **Retinal Detachment**.

Q: "Puff-ball" opacities in the vitreous are pathognomonic of which condition?

Fungal endophthalmitis. **Explanation:** **Fungal Endophthalmitis** (Correct Answer) is characterized by the presence of discrete, fluffy, white, round opacities in the vitreous humor. These are classically described as **"Puff-balls"** or **"Cotton-balls."** When these opacities are linked together by inflammatory strands, they create the **"String of pearls"** appearance. These findings represent focal collections of fungi (most commonly *Candida albicans*) and inflammatory cells. This is a high-yield clinical sign used to differentiate fungal etiology from bacterial endophthalmitis, which typically presents with a more diffuse, hazy vitritis. **Analysis of Incorrect Options:** * **Pars planitis:** This is a form of intermediate uveitis characterized by **"Snowballs"** (white inflammatory aggregates in the inferior vitreous) and **"Snowbanking"** (exudates over the pars plana). While similar in name, "Puff-balls" is the specific terminology reserved for fungal infections. * **Exudative retinopathy of Coats:** This is a non-inflammatory vascular disease characterized by telangiectatic vessels and massive subretinal yellow exudates. It does not typically present with vitreous opacities. * **Sympathetic ophthalmitis:** This is a bilateral granulomatous panuveitis following trauma. Its hallmark pathological finding is **Dalen-Fuchs nodules** (sub-RPE nodules), not vitreous puff-balls. **High-Yield Clinical Pearls for NEET-PG:** * **"String of pearls":** Pathognomonic for Fungal Endophthalmitis (Candida). * **"Snowbanking/Snowballs":** Pathognomonic for Pars Planitis. * **Treatment of choice for Fungal Endophthalmitis:** Intravitreal Amphotericin B or Voriconazole. * **Commonest cause of Endogenous Fungal Endophthalmitis:** *Candida albicans* (often associated with IV drug use or long-term indwelling catheters).

Q: What is the normal A:V ratio of retinal blood vessels?

2:3. **Explanation:** In a healthy retina, the **Arteriole-to-Venule (A:V) ratio** is a critical clinical marker used to assess systemic vascular health. Under normal physiological conditions, retinal arterioles are slightly narrower than the corresponding venules. The standard normal ratio is **2:3** (or approximately 0.6 to 0.7). **Why 2:3 is correct:** Retinal venules are naturally more distensible and carry a larger volume of blood at lower pressure compared to arterioles, making them appear wider on ophthalmoscopy. This 2:3 ratio serves as the baseline for evaluating vascular pathology. **Analysis of Incorrect Options:** * **A. 1:2:** This indicates significant **arteriolar narrowing**. A ratio of 1:2 or less is a hallmark of pathological conditions like Hypertensive Retinopathy (Grade II/III) or retinal artery occlusion. * **C. 3:2:** This is mathematically incorrect as it suggests arterioles are wider than veins, which does not occur in normal human anatomy. * **D. 3:4:** While closer to normal than 1:2, it overestimates the width of the arteriole relative to the venule in a standard clinical setting. **High-Yield Clinical Pearls for NEET-PG:** 1. **Hypertensive Retinopathy:** The earliest sign is generalized arteriolar narrowing (A:V ratio decreases). 2. **A/V Nipping (Gunn’s Sign):** Occurs because the arteriole and venule share a common adventitial sheath; a thickened arteriole compresses the venule. 3. **Venous Tortuosity/Dilatation:** An increase in the denominator (venule width) occurs in Central Retinal Vein Occlusion (CRVO), papilledema, and hyperviscosity syndromes. 4. **Silver/Copper Wiring:** Reflects increased light reflex from the arteriolar wall due to atherosclerosis/hypertension.

Q: Which of the following tumors can present with a white reflex in the pupil?

Retinoblastoma. **Explanation:** The clinical presentation of a white reflex in the pupil is known as **Leukocoria**. This occurs when an intraocular mass or opacity reflects light back through the pupil instead of the normal red reflex from the vascular choroid. **1. Why Retinoblastoma is correct:** Retinoblastoma is the most common primary intraocular malignancy of childhood. It arises from the neurosensory retina. As the tumor grows (endophytic or exophytic), it forms a creamy-white, vascularized mass within the eye. This mass reflects the light of an ophthalmoscope, resulting in **leukocoria**, which is the most common presenting sign (60% of cases), followed by strabismus. **2. Why the other options are incorrect:** * **Squamous cell carcinoma (SCC):** In the ocular context, this typically affects the conjunctiva or eyelids (surface structures). It presents as a fleshy growth or ulcer, not an intraocular mass causing leukocoria. * **Neurofibroma:** These are benign nerve sheath tumors. While associated with Neurofibromatosis Type 1 (which features Lisch nodules on the iris), they do not typically form large intraocular masses that obscure the red reflex. * **Keratoacanthoma:** This is a fast-growing, low-grade skin tumor (often on the eyelid) characterized by a central keratinous plug. It is an external adnexal lesion and cannot cause a pupillary reflex change. **Clinical Pearls for NEET-PG:** * **Differential Diagnosis of Leukocoria:** Retinoblastoma (most common life-threatening cause), Congenital Cataract (most common overall cause), Coats’ disease, Persistent Fetal Vasculature (PFV), and Retinopathy of Prematurity (ROP). * **Calcification:** The presence of intraocular calcification on CT/Ultrasound is highly suggestive of Retinoblastoma (Dystrophic calcification). * **Flexner-Wintersteiner Rosettes:** These are pathognomonic histological features of Retinoblastoma.

Q: Through which vessel is dye injected for a retinal artery angiogram?

Antecubital vein. **Explanation:** The standard procedure for visualizing the retinal vasculature is **Fundus Fluorescein Angiography (FFA)**. Despite the name "artery angiogram," the dye (Sodium Fluorescein) is injected into the systemic venous circulation, most commonly via the **antecubital vein**. **Why the Antecubital Vein is Correct:** The antecubital vein is the preferred site because it is easily accessible and allows for a rapid bolus injection. Once injected, the dye follows the venous return to the heart (Right Atrium → Right Ventricle → Lungs → Left Atrium → Left Ventricle) and enters the systemic arterial circulation via the aorta. It reaches the eye through the Internal Carotid Artery and finally the Ophthalmic Artery. The transit time from the arm to the retina (Arm-to-Retina time) is typically **8 to 14 seconds**. **Why Other Options are Incorrect:** * **Retinal Artery:** Direct injection is anatomically impossible and clinically dangerous; the retinal artery is a terminal branch inside the eye. * **Ophthalmic Artery:** While this is the artery that supplies the eye, direct catheterization is invasive and unnecessary for routine diagnostic imaging. * **Femoral Vein:** While it could technically reach the heart, it is unnecessarily invasive compared to the antecubital vein and is not the standard of care. **High-Yield Clinical Pearls for NEET-PG:** * **Dye Used:** 5-10 ml of **10% Sodium Fluorescein** (most common) or 25% (smaller volume). * **Filter System:** Uses a **Cobalt Blue** exciter filter (465-490 nm) and a **Yellow-Green** barrier filter (520-530 nm). * **Side Effects:** Nausea (most common), yellowish skin/urine discoloration (transient). * **Contraindication:** History of severe anaphylaxis to the dye. * **Phases of FFA:** Pre-arterial (Choroidal flush) → Arterial → Arteriovenous (Capillary) → Venous → Recirculation/Late phase.

Q: What is the treatment for a small retinoblastoma tumor?

Brachytherapy. **Explanation:** The management of Retinoblastoma (RB) has shifted from life-saving enucleation to **eye-salvage treatments**, depending on the tumor's size, location, and staging (ICRB classification). **Why Brachytherapy is correct:** For **small, localized tumors** (typically <12 mm in diameter and <6 mm in thickness) that are not involving the optic disc or fovea, **local destructive therapy** is the treatment of choice. Brachytherapy (plaque radiotherapy using Iodine-125 or Ruthenium-106) allows for the delivery of high-dose radiation directly to the tumor site while sparing surrounding healthy ocular tissues. Other focal options for small tumors include cryotherapy (for anterior tumors) and transpupillary thermotherapy (TTT). **Analysis of Incorrect Options:** * **Enucleation:** This is the treatment of choice for **large, advanced tumors** (Group E) where there is no hope for vision, or if there is involvement of the optic nerve, glaucoma, or anterior chamber spread. * **Evisceration:** This is **strictly contraindicated** in suspected intraocular malignancies like retinoblastoma, as it risks extraocular seeding of malignant cells. * **Chemotherapy:** While systemic chemotherapy (Chemoreduction) is used to shrink medium-to-large tumors (Groups B, C, and D) to make them amenable to focal therapy, it is generally not the primary standalone treatment for a very small, isolated tumor that can be cured with local plaque radiotherapy. **High-Yield Clinical Pearls for NEET-PG:** * **Most common intraocular tumor of childhood:** Retinoblastoma. * **Most common presenting sign:** Leukocoria (White pupillary reflex), followed by strabismus. * **Pathognomonic Histology:** Flexner-Wintersteiner rosettes. * **Calcification:** Present in 90% of cases (visible on CT/Ultrasound); a key diagnostic feature. * **Gene:** RB1 gene on Chromosome 13q14.

Q: A patient with Non-Insulin Dependent Diabetes Mellitus (NIDDM) diagnosed for one year should have an ophthalmic examination:

As early as feasible. **Explanation:** The timing of the initial ophthalmic screening for Diabetic Retinopathy (DR) depends primarily on the type of Diabetes Mellitus (DM). **Why Option A is correct:** In **Type 2 DM (NIDDM)**, the exact onset of the disease is often unknown and asymptomatic. Patients may have had undiagnosed hyperglycemia for years before clinical diagnosis. Consequently, significant microvascular damage, including retinopathy, may already be present at the time of diagnosis. Therefore, the recommendation is to perform a dilated fundus examination **as early as feasible** or at the time of diagnosis. **Why other options are incorrect:** * **Option B & C:** A 5-year delay is the standard for **Type 1 DM**, where the onset is acute and the risk of retinopathy in the first few years is negligible. Applying this to Type 2 DM would lead to missed diagnoses of existing vision-threatening conditions. * **Option D:** Diabetic retinopathy is often asymptomatic in its early, treatable stages (like NPDR or Macular Edema). Waiting for visual symptoms usually means the disease has progressed to advanced stages (PDR), where the prognosis is poorer. **High-Yield Clinical Pearls for NEET-PG:** * **Type 1 DM Screening:** Start 5 years after diagnosis. * **Type 2 DM Screening:** Start at the time of diagnosis. * **Pregnancy and DM:** Patients with pre-existing DM who become pregnant should be examined in the **first trimester** and followed closely throughout pregnancy (risk of rapid progression). * **Follow-up:** If no retinopathy is found, screening is typically repeated **annually**. * **Earliest Sign:** Microaneurysms in the Inner Nuclear Layer (INL).

Q: A 50-year-old patient with signs of peripheral neuropathy is found to have diabetes mellitus. He has no ocular symptoms. When should this patient be referred for a retina evaluation?

Immediately after diagnosis. ### Explanation **Correct Answer: B. Immediately after diagnosis** The timing of the initial retinal examination in diabetic patients is a high-yield concept based on the pathophysiology of the disease. In **Type 2 Diabetes Mellitus (T2DM)**, the exact onset of the disease is often unknown and can precede clinical diagnosis by several years. By the time a patient is diagnosed with T2DM, microvascular complications (like diabetic retinopathy) may already be present. Therefore, the **American Academy of Ophthalmology (AAO)** and **ADA** guidelines recommend a comprehensive eye exam **at the time of diagnosis**. **Analysis of Incorrect Options:** * **A. When ocular symptoms develop:** This is dangerous. Diabetic retinopathy is often asymptomatic until it reaches advanced stages (e.g., vitreous hemorrhage or macular edema). Waiting for symptoms means missing the window for vision-saving intervention. * **C. When insulin therapy is required:** The need for insulin indicates disease progression or poor control, but it is not the trigger for the first screening. Screening must occur regardless of the treatment modality. * **D. Five years after diagnosis:** This is the protocol for **Type 1 Diabetes Mellitus (T1DM)**. Since the onset of T1DM is usually acute and identifiable, retinopathy rarely develops within the first 5 years. **NEET-PG Clinical Pearls:** * **Type 1 DM:** First screening 5 years after diagnosis. * **Type 2 DM:** First screening at the time of diagnosis. * **Pregnancy in DM:** Patients with pre-existing DM should be screened in the first trimester and then every 1–3 months (Pregnancy can rapidly accelerate retinopathy). * **Follow-up:** Generally, annual screening is recommended if no retinopathy is found. * **Earliest Clinical Sign:** Microaneurysms (found in the inner nuclear layer). * **Earliest Pathological Sign:** Loss of pericytes and basement membrane thickening.

Q: Argus 2 implants have been experimentally tried in which of the following conditions?

Retinitis pigmentosa. **Explanation:** The **Argus II Retinal Prosthesis System**, often referred to as the "bionic eye," is an electronic retinal implant designed to provide electrical stimulation of the retina to induce visual perception. **Why Retinitis Pigmentosa (RP) is correct:** In RP, there is progressive degeneration of photoreceptors (rods and cones), but the inner retinal layers (bipolar and ganglion cells) and the optic nerve often remain functionally intact for a long period. The Argus II bypasses the dead photoreceptors by using an external camera to capture images, which are converted into electrical pulses. These pulses are sent to an epiretinal electrode array that stimulates the surviving inner retinal neurons, allowing the patient to perceive patterns of light. **Why other options are incorrect:** * **Advanced Glaucoma & Optic Atrophy:** These conditions involve damage to the **ganglion cells and the optic nerve**. Since the Argus II relies on a functional optic nerve to transmit signals from the retina to the brain, it cannot restore vision if the nerve itself is atrophied. * **Failed Penetrating Keratoplasty:** This is a corneal pathology. Vision loss due to corneal opacity is treated with repeat keratoplasty or a **Keratoprosthesis (e.g., Boston K-pro)**, not a retinal implant. **High-Yield Facts for NEET-PG:** * **FDA Approval:** Argus II was the first "bionic eye" approved for patients with severe to profound RP. * **Implant Location:** It is an **epiretinal** implant (placed on the surface of the retina). * **Patient Selection:** It is indicated only for patients with bare light perception or worse, who have a functional optic nerve. * **Other Retinal Prostheses:** Alpha-IMS (subretinal) and Orion (cortical visual prosthesis—used if the optic nerve is damaged).

Question 1

A patient presented with sudden onset of floaters and perception of a curtain (veil) falling in front of the eye. Which one of the following is the most appropriate diagnosis?

Accepted Answer

Retinal detachment

Answer

Eales disease

Answer

Vitreous hemorrhage

Answer

Glaucoma

Question 2

"Puff-ball" opacities in the vitreous are pathognomonic of which condition?

Accepted Answer

Fungal endophthalmitis

Answer

Pars planitis

Answer

Exudative retinopathy of Coats

Answer

Sympathetic ophthalmitis

Question 3

What is the normal A:V ratio of retinal blood vessels?

Accepted Answer

2:3

Answer

1:2

Answer

3:2

Answer

3:4

Question 4

Which of the following tumors can present with a white reflex in the pupil?

Accepted Answer

Retinoblastoma

Answer

Squamous cell carcinoma

Answer

Neurofibroma

Answer

Keratoacanthoma

Question 5

Through which vessel is dye injected for a retinal artery angiogram?

Accepted Answer

Antecubital vein

Answer

Retinal artery

Answer

Ophthalmic artery

Answer

Femoral vein

Question 6

A cherry red spot is seen in which of the following conditions, except?

Accepted Answer

Multiple aromatase deficiency

Answer

Hunter syndrome

Answer

Hallervorden-Spatz disease

Answer

Goldberg's disease

Question 7

What is the treatment for a small retinoblastoma tumor?

Accepted Answer

Brachytherapy

Answer

Enucleation

Answer

Eviceration

Answer

Chemotherapy

Question 8

A patient with Non-Insulin Dependent Diabetes Mellitus (NIDDM) diagnosed for one year should have an ophthalmic examination:

Accepted Answer

As early as feasible

Answer

After 5 years

Answer

After 10 years

Answer

Only after visual symptoms develop

Question 9

A 50-year-old patient with signs of peripheral neuropathy is found to have diabetes mellitus. He has no ocular symptoms. When should this patient be referred for a retina evaluation?

Accepted Answer

Immediately after diagnosis

Answer

When ocular symptoms develop

Answer

When insulin therapy is required for blood sugar control

Answer

Five years after diagnosis

Question 10

Argus 2 implants have been experimentally tried in which of the following conditions?

Accepted Answer

Retinitis pigmentosa

Answer

Advanced Glaucoma

Answer

Optic atrophy

Answer

Failed penetrating keratoplasty

Diseases of the Retina — MCQs

Diseases of the Retina — MCQs

On this page

Practice by Chapter

Want unlimited practice?